InSimili s.r.l. is a private biotechnology company that aims to bring to the market a patented technology, which will revolutionize the drug selection process. Our product can recreate the microenvironment of pathological and physiological conditions in standard cell culture containers. Our solution bridges the gap between patients and in vitro studies, enabling a better evaluation of the real efficacy of innovative treatments. By selecting better drug candidates early, pharmaceutical companies can minimize the risk of failures in the clinical phases, saving time and billions of dollars.
| Website | http://www.insimili.com |
| Employees | 5 (2 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Drug Discovery, Drug Development, Pharmaceutical Technology, Precision Medicine, Therapeutic Solutions, Disease Modeling, Biomedical Research, Health Technology, Life Sciences, Innovative Therapies, Patented Technology, Pharmaceutical Research, Biotech Solutions, Clinical Trials, Drug Design, Medical Technology, In Vitro Models |
Looking for a particular InSimili employee's phone or email?
Stefania Rapino is the CTO of InSimili.
2 people are employed at InSimili.